United Health Products Announces Distributor to the Veterinarian Market
21 Mars 2012 - 2:27PM
Marketwired
United Health Products, Inc. (OTCQB: UEEC) (PINKSHEETS: UEEC),
which develops and markets products and technologies in the
healthcare sector, today announced that Epic Wound Care Inc., its
wholly-owned subsidiary, has executed a Distribution Agreement with
BioVentive Inc. for the exclusive rights to distribute its
Hemostyp™ product line into the veterinarian market both
domestically and internationally.
In the United States, the American Pet Products Association
estimates that 62% of all households own a pet (i.e., dog, cat,
horse, bird, fish or reptile) which equates to 72.9 million homes.
The American Veterinary Medical Association estimates that the
number of procedures performed on animals, whether due to injury or
health related issues exceeds 10 million, annually. Hemostyp gauze
technology is designed to absorb exudate/drainage from superficial
wounds and assists the veterinarian in expediting the delivery of
service.
Dr. Phillip Forman, United's CEO, said, "I am very excited about
Epic entering into this agreement with BioVentive to promote our
products in the veterinarian market. The absorption quality
inherent in our Hemostyp products can now be implemented in
numerous fashions in the treatment of pets including tooth
extractions and superficial trauma."
"Hemostyp is the key product line that helps position our
company to offer advanced life saving technology, at the right
price, to achieve significant market share in the worldwide
veterinarian market over the next 12 months," says Brett Nauta,
President of BioVentive, Inc."
About United Health Products, Inc. United
Health Products, Inc. (UEEC) develops, manufactures and markets
products and technologies in the healthcare sector. UEEC's
operating subsidiary Epic Wound Care, Inc. produces hemostatic
gauze, derived from regenerated oxidized cellulose, which is all
natural and designed to absorb exudate/drainage from superficial
wounds. UEEC is focused on identifying emerging healthcare products
and technologies for strategic partnership or acquisition.
About BioVentive, Inc. BioVentive is a
private company based in California that sells and distributes
products to the medical and veterinary markets. BioVentive markets
products that consist of enhanced infection prevention solutions,
stem cell therapies and collection, and specialized wound care
products and solutions. Its over 100 member sales force includes
specialists to service the genetic therapy and wound care
management in the veterinarian market. The company works both as a
direct re-seller and channel partner of major worldwide
distributors.
Safe Harbor Statement Safe Harbor
Statement under the Private Securities Litigation Reform Act of
1995: This news release may contain forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes,"
"expects," "anticipates" or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking
statements.
Contact: Dr. Philip Forman Chairman and CEO United Health
Products, Inc. (646) 961-4459
United Health Products (PK) (USOTC:UEEC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
United Health Products (PK) (USOTC:UEEC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024